Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $4.21 Analyst target: $5.46 Upside: 29.69%
Arbutus Biopharma Corporation, a biopharmaceutical company, is dedicated to the discovery, development, and commercialization of a cure for patients with chronic hepatitis B virus (HBV) infection in the United States. The company is headquartered in Warminster, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.